▶ 調査レポート

世界の小児神経芽細胞腫の治療市場:市場規模・現状・予測

• 英文タイトル:Global Pediatric Neuroblastoma Treatment Market Size, Status and Forecast 2019-2025

QYResearchが調査・発行した産業分析レポートです。世界の小児神経芽細胞腫の治療市場:市場規模・現状・予測 / Global Pediatric Neuroblastoma Treatment Market Size, Status and Forecast 2019-2025 / QYR9N7781資料のイメージです。• レポートコード:QYR9N7781
• 出版社/出版日:QYResearch / 2019年6月14日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、92ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:医療・製薬・バイオ
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Enterprise License¥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当資料は、小児神経芽細胞腫の治療のグローバル市場について調査・分析したレポートで、種類別(免疫療法、化学療法、その他)、用途別(病院、診療所、その他)、主要地域別(アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米)の市場規模、市場予測、関連企業情報などが含まれています。

・小児神経芽細胞腫の治療の世界市場規模
・主要企業別市場シェア
・小児神経芽細胞腫の治療の世界市場規模:種類別(免疫療法、化学療法、その他)
・小児神経芽細胞腫の治療の世界市場規模:用途別(病院、診療所、その他)
・小児神経芽細胞腫の治療のアメリカ市場規模(種類別、用途別)
・小児神経芽細胞腫の治療のヨーロッパ市場規模(種類別、用途別)
・小児神経芽細胞腫の治療の中国市場規模(種類別、用途別)
・小児神経芽細胞腫の治療の日本市場規模(種類別、用途別)
・小児神経芽細胞腫の治療の東南アジア市場規模(種類別、用途別)
・小児神経芽細胞腫の治療のインド市場規模(種類別、用途別)
・小児神経芽細胞腫の治療の中南米市場規模(種類別、用途別)
・主要企業別分析(企業概要、製品動向、販売量など)
・小児神経芽細胞腫の治療の世界市場予測(2019年-2025年)
・小児神経芽細胞腫の治療の地域別市場予測(2019年-2025年)
...

In terms of therapy type, the market has been classified into immunotherapy, chemotherapy, and others. The chemotherapy segment held leading market share in 2017.Based on distribution channel, the global pediatric neuroblastoma treatment market has been categorized into hospital pharmacies and retail pharmacies & drug stores. The hospital pharmacies segment dominated the market in 2017 and is expected to retain its leadership position in terms of market share during the forecast period.
In 2018, the global Pediatric Neuroblastoma Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Pediatric Neuroblastoma Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Pediatric Neuroblastoma Treatment development in United States, Europe and China.

The key players covered in this study
United Therapeutics
Apeiron Biologics
Pfizer
Bayer
Baxter
Cellectar Biosciences
MacroGenics

Market segment by Type, the product can be split into
Immunotherapy
Chemotherapy
Others

Market segment by Application, split into
Hospitals
Clinics
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Pediatric Neuroblastoma Treatment status, future forecast, growth opportunity, key market and key players.
To present the Pediatric Neuroblastoma Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Pediatric Neuroblastoma Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Pediatric Neuroblastoma Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Immunotherapy
1.4.3 Chemotherapy
1.4.4 Others
1.5 Market by Application
1.5.1 Global Pediatric Neuroblastoma Treatment Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Pediatric Neuroblastoma Treatment Market Size
2.2 Pediatric Neuroblastoma Treatment Growth Trends by Regions
2.2.1 Pediatric Neuroblastoma Treatment Market Size by Regions (2014-2025)
2.2.2 Pediatric Neuroblastoma Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Pediatric Neuroblastoma Treatment Market Size by Manufacturers
3.1.1 Global Pediatric Neuroblastoma Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Pediatric Neuroblastoma Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Pediatric Neuroblastoma Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Pediatric Neuroblastoma Treatment Key Players Head office and Area Served
3.3 Key Players Pediatric Neuroblastoma Treatment Product/Solution/Service
3.4 Date of Enter into Pediatric Neuroblastoma Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Pediatric Neuroblastoma Treatment Market Size by Type (2014-2019)
4.2 Global Pediatric Neuroblastoma Treatment Market Size by Application (2014-2019)

5 United States
5.1 United States Pediatric Neuroblastoma Treatment Market Size (2014-2019)
5.2 Pediatric Neuroblastoma Treatment Key Players in United States
5.3 United States Pediatric Neuroblastoma Treatment Market Size by Type
5.4 United States Pediatric Neuroblastoma Treatment Market Size by Application

6 Europe
6.1 Europe Pediatric Neuroblastoma Treatment Market Size (2014-2019)
6.2 Pediatric Neuroblastoma Treatment Key Players in Europe
6.3 Europe Pediatric Neuroblastoma Treatment Market Size by Type
6.4 Europe Pediatric Neuroblastoma Treatment Market Size by Application

7 China
7.1 China Pediatric Neuroblastoma Treatment Market Size (2014-2019)
7.2 Pediatric Neuroblastoma Treatment Key Players in China
7.3 China Pediatric Neuroblastoma Treatment Market Size by Type
7.4 China Pediatric Neuroblastoma Treatment Market Size by Application

8 Japan
8.1 Japan Pediatric Neuroblastoma Treatment Market Size (2014-2019)
8.2 Pediatric Neuroblastoma Treatment Key Players in Japan
8.3 Japan Pediatric Neuroblastoma Treatment Market Size by Type
8.4 Japan Pediatric Neuroblastoma Treatment Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Pediatric Neuroblastoma Treatment Market Size (2014-2019)
9.2 Pediatric Neuroblastoma Treatment Key Players in Southeast Asia
9.3 Southeast Asia Pediatric Neuroblastoma Treatment Market Size by Type
9.4 Southeast Asia Pediatric Neuroblastoma Treatment Market Size by Application

10 India
10.1 India Pediatric Neuroblastoma Treatment Market Size (2014-2019)
10.2 Pediatric Neuroblastoma Treatment Key Players in India
10.3 India Pediatric Neuroblastoma Treatment Market Size by Type
10.4 India Pediatric Neuroblastoma Treatment Market Size by Application

11 Central & South America
11.1 Central & South America Pediatric Neuroblastoma Treatment Market Size (2014-2019)
11.2 Pediatric Neuroblastoma Treatment Key Players in Central & South America
11.3 Central & South America Pediatric Neuroblastoma Treatment Market Size by Type
11.4 Central & South America Pediatric Neuroblastoma Treatment Market Size by Application

12 International Players Profiles
12.1 United Therapeutics
12.1.1 United Therapeutics Company Details
12.1.2 Company Description and Business Overview
12.1.3 Pediatric Neuroblastoma Treatment Introduction
12.1.4 United Therapeutics Revenue in Pediatric Neuroblastoma Treatment Business (2014-2019)
12.1.5 United Therapeutics Recent Development
12.2 Apeiron Biologics
12.2.1 Apeiron Biologics Company Details
12.2.2 Company Description and Business Overview
12.2.3 Pediatric Neuroblastoma Treatment Introduction
12.2.4 Apeiron Biologics Revenue in Pediatric Neuroblastoma Treatment Business (2014-2019)
12.2.5 Apeiron Biologics Recent Development
12.3 Pfizer
12.3.1 Pfizer Company Details
12.3.2 Company Description and Business Overview
12.3.3 Pediatric Neuroblastoma Treatment Introduction
12.3.4 Pfizer Revenue in Pediatric Neuroblastoma Treatment Business (2014-2019)
12.3.5 Pfizer Recent Development
12.4 Bayer
12.4.1 Bayer Company Details
12.4.2 Company Description and Business Overview
12.4.3 Pediatric Neuroblastoma Treatment Introduction
12.4.4 Bayer Revenue in Pediatric Neuroblastoma Treatment Business (2014-2019)
12.4.5 Bayer Recent Development
12.5 Baxter
12.5.1 Baxter Company Details
12.5.2 Company Description and Business Overview
12.5.3 Pediatric Neuroblastoma Treatment Introduction
12.5.4 Baxter Revenue in Pediatric Neuroblastoma Treatment Business (2014-2019)
12.5.5 Baxter Recent Development
12.6 Cellectar Biosciences
12.6.1 Cellectar Biosciences Company Details
12.6.2 Company Description and Business Overview
12.6.3 Pediatric Neuroblastoma Treatment Introduction
12.6.4 Cellectar Biosciences Revenue in Pediatric Neuroblastoma Treatment Business (2014-2019)
12.6.5 Cellectar Biosciences Recent Development
12.7 MacroGenics
12.7.1 MacroGenics Company Details
12.7.2 Company Description and Business Overview
12.7.3 Pediatric Neuroblastoma Treatment Introduction
12.7.4 MacroGenics Revenue in Pediatric Neuroblastoma Treatment Business (2014-2019)
12.7.5 MacroGenics Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Pediatric Neuroblastoma Treatment Key Market Segments
Table Key Players Pediatric Neuroblastoma Treatment Covered
Table Global Pediatric Neuroblastoma Treatment Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Pediatric Neuroblastoma Treatment Market Size Market Share by Type 2014-2025
Figure Immunotherapy Figures
Table Key Players of Immunotherapy
Figure Chemotherapy Figures
Table Key Players of Chemotherapy
Figure Others Figures
Table Key Players of Others
Table Global Pediatric Neuroblastoma Treatment Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Others Case Studies
Figure Pediatric Neuroblastoma Treatment Report Years Considered
Table Global Pediatric Neuroblastoma Treatment Market Size 2014-2025 (Million US$)
Figure Global Pediatric Neuroblastoma Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Pediatric Neuroblastoma Treatment Market Size by Regions 2014-2025 (Million US$)
Table Global Pediatric Neuroblastoma Treatment Market Size by Regions 2014-2019 (Million US$)
Table Global Pediatric Neuroblastoma Treatment Market Share by Regions 2014-2019
Figure Global Pediatric Neuroblastoma Treatment Market Share by Regions 2014-2019
Figure Global Pediatric Neuroblastoma Treatment Market Share by Regions 2019
Table Market Top Trends
Table Global Pediatric Neuroblastoma Treatment Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Pediatric Neuroblastoma Treatment Market Share by Manufacturers (2014-2019)
Figure Global Pediatric Neuroblastoma Treatment Market Share by Manufacturers in 2018
Table Global Pediatric Neuroblastoma Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Pediatric Neuroblastoma Treatment Product/Solution/Service
Table Date of Enter into Pediatric Neuroblastoma Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Pediatric Neuroblastoma Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Pediatric Neuroblastoma Treatment Market Size Share by Type (2014-2019)
Figure Global Pediatric Neuroblastoma Treatment Market Size Market Share by Type (2014-2019)
Table Global Pediatric Neuroblastoma Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Pediatric Neuroblastoma Treatment Market Size Share by Application (2014-2019)
Figure Global Pediatric Neuroblastoma Treatment Market Size Market Share by Application (2014-2019)
Figure Global Pediatric Neuroblastoma Treatment Revenue Market Share by Application in 2018
Figure United States Pediatric Neuroblastoma Treatment Market Size 2014-2019 (Million US$)
Table United States Key Players Pediatric Neuroblastoma Treatment Revenue (2018-2019) (Million US$)
Table United States Key Players Pediatric Neuroblastoma Treatment Market Share (2018-2019)
Table United States Pediatric Neuroblastoma Treatment Market Size by Type (2014-2019) (Million US$)
Table United States Pediatric Neuroblastoma Treatment Market Share by Type (2014-2019)
Table United States Pediatric Neuroblastoma Treatment Market Size by Application (2014-2019) (Million US$)
Table United States Pediatric Neuroblastoma Treatment Market Share by Application (2014-2019)
Figure Europe Pediatric Neuroblastoma Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Pediatric Neuroblastoma Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Pediatric Neuroblastoma Treatment Market Share (2018-2019)
Table Europe Pediatric Neuroblastoma Treatment Market Size by Type (2014-2019) (Million US$)
Table Europe Pediatric Neuroblastoma Treatment Market Share by Type (2014-2019)
Table Europe Pediatric Neuroblastoma Treatment Market Size by Application (2014-2019) (Million US$)
Table Europe Pediatric Neuroblastoma Treatment Market Share by Application (2014-2019)
Figure China Pediatric Neuroblastoma Treatment Market Size 2014-2019 (Million US$)
Table China Key Players Pediatric Neuroblastoma Treatment Revenue (2018-2019) (Million US$)
Table China Key Players Pediatric Neuroblastoma Treatment Market Share (2018-2019)
Table China Pediatric Neuroblastoma Treatment Market Size by Type (2014-20189) (Million US$)
Table China Pediatric Neuroblastoma Treatment Market Share by Type (2014-2019)
Table China Pediatric Neuroblastoma Treatment Market Size by Application (2014-2019) (Million US$)
Table China Pediatric Neuroblastoma Treatment Market Share by Application (2014-2019)
Figure Japan Pediatric Neuroblastoma Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players Pediatric Neuroblastoma Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players Pediatric Neuroblastoma Treatment Market Share (2018-2019)
Table Japan Pediatric Neuroblastoma Treatment Market Size by Type (2014-2019) (Million US$)
Table Japan Pediatric Neuroblastoma Treatment Market Share by Type (2014-2019)
Table Japan Pediatric Neuroblastoma Treatment Market Size by Application (2014-2019) (Million US$)
Table Japan Pediatric Neuroblastoma Treatment Market Share by Application (2014-2019)
Figure Southeast Asia Pediatric Neuroblastoma Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Pediatric Neuroblastoma Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Pediatric Neuroblastoma Treatment Market Share (2018-2019)
Table Southeast Asia Pediatric Neuroblastoma Treatment Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Pediatric Neuroblastoma Treatment Market Share by Type (2014-2019)
Table Southeast Asia Pediatric Neuroblastoma Treatment Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Pediatric Neuroblastoma Treatment Market Share by Application (2014-2019)
Figure India Pediatric Neuroblastoma Treatment Market Size 2014-2019 (Million US$)
Table India Key Players Pediatric Neuroblastoma Treatment Revenue (2018-2019) (Million US$)
Table India Key Players Pediatric Neuroblastoma Treatment Market Share (2018-2019)
Table India Pediatric Neuroblastoma Treatment Market Size by Type (2014-2019) (Million US$)
Table India Pediatric Neuroblastoma Treatment Market Share by Type (2014-2019)
Table India Pediatric Neuroblastoma Treatment Market Size by Application (2014-2019) (Million US$)
Table India Pediatric Neuroblastoma Treatment Market Share by Application (2014-2019)
Figure Central & South America Pediatric Neuroblastoma Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Pediatric Neuroblastoma Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Pediatric Neuroblastoma Treatment Market Share (2018-2019)
Table Central & South America Pediatric Neuroblastoma Treatment Market Size by Type (2014-2019) (Million US$)
Table Central & South America Pediatric Neuroblastoma Treatment Market Share by Type (2014-2019)
Table Central & South America Pediatric Neuroblastoma Treatment Market Size by Application (2014-2019) (Million US$)
Table Central & South America Pediatric Neuroblastoma Treatment Market Share by Application (2014-2019)
Table United Therapeutics Company Details
Table United Therapeutics Revenue in Pediatric Neuroblastoma Treatment Business (2014-2019) (Million US$)
Figure United Therapeutics Revenue Growth Rate in Pediatric Neuroblastoma Treatment Business (2014-2019)
Table United Therapeutics Recent Development
Table Apeiron Biologics Company Details
Table Apeiron Biologics Revenue in Pediatric Neuroblastoma Treatment Business (2014-2019)(Million US$)
Figure Apeiron Biologics Revenue Growth Rate in Pediatric Neuroblastoma Treatment Business (2014-2019)
Table Apeiron Biologics Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Pediatric Neuroblastoma Treatment Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Pediatric Neuroblastoma Treatment Business (2014-2019)
Table Pfizer Recent Development
Table Bayer Company Details
Table Bayer Revenue in Pediatric Neuroblastoma Treatment Business (2014-2019)(Million US$)
Figure Bayer Revenue Growth Rate in Pediatric Neuroblastoma Treatment Business (2014-2019)
Table Bayer Recent Development
Table Baxter Company Details
Table Baxter Revenue in Pediatric Neuroblastoma Treatment Business (2014-2019)(Million US$)
Figure Baxter Revenue Growth Rate in Pediatric Neuroblastoma Treatment Business (2014-2019)
Table Baxter Recent Development
Table Cellectar Biosciences Company Details
Table Cellectar Biosciences Revenue in Pediatric Neuroblastoma Treatment Business (2014-2019)(Million US$)
Figure Cellectar Biosciences Revenue Growth Rate in Pediatric Neuroblastoma Treatment Business (2014-2019)
Table Cellectar Biosciences Recent Development
Table MacroGenics Company Details
Table MacroGenics Revenue in Pediatric Neuroblastoma Treatment Business (2014-2019)(Million US$)
Figure MacroGenics Revenue Growth Rate in Pediatric Neuroblastoma Treatment Business (2014-2019)
Table MacroGenics Recent Development
Table Global Pediatric Neuroblastoma Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Pediatric Neuroblastoma Treatment Market Size Share by Regions (2019-2025)
Figure Global Pediatric Neuroblastoma Treatment Market Size Share by Regions in 2025
Figure United States Pediatric Neuroblastoma Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Pediatric Neuroblastoma Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China Pediatric Neuroblastoma Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan Pediatric Neuroblastoma Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Pediatric Neuroblastoma Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India Pediatric Neuroblastoma Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Pediatric Neuroblastoma Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Pediatric Neuroblastoma Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Pediatric Neuroblastoma Treatment Market Size by Product (2019-2025)
Figure Global Pediatric Neuroblastoma Treatment Market Size by Product in 2025
Table Global Pediatric Neuroblastoma Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Pediatric Neuroblastoma Treatment Market Size by Application (2019-2025)
Figure Global Pediatric Neuroblastoma Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources